Skip to main content

Par Technology Corp(PAR-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

PARADIGM BIOPHARMACEUTICALS LTD. APPOINTS MARCO POLIZZI as CHIEF EXECUTIVE OFFICER

PR Newswire - Mon Jun 27, 2022

Polizzi Possesses More Than 30 Years of Experience in the Pharmaceutical Industry.

NEW YORK, June 27, 2022 /PRNewswire/ -- Paradigm Biopharmaceuticals Ltd (ASX: PAR) ("Paradigm" or "the Company"), a clinical-stage biopharmaceutical company focused on repurposing existing molecules for new indications with unmet clinical needs, appointed experienced pharmaceutical industry executive Marco Polizzi as its full-time Chief Executive Officer (CEO), effective July 1, 2022.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).